Computational analysis of mrna expression profiles identifies microRNA-29a/c as predictor of colorectal cancer early recurrence

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Kuo, Tai Yue ^a   Hsi, Edward ^a,b   Yang, I Ping ^a,c   Tsai, Pei Chien ^a   Wang, Jaw Yuan ^a,b   Juo, Suh Hang Hank ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c SHU ZEN COLLEGE OF MEDICINE AND MANAGEMENT   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; MICRORNA; MICRORNA 29A; MICRORNA 29C; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; MIRN29 MICRORNA, HUMAN;

ARTICLE; CANCER RECURRENCE; COLORECTAL CANCER; COLORECTAL SURGERY; COMPUTER PROGRAM; CONTROLLED STUDY; DATA EXTRACTION; DISTANT METASTASIS; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE TARGETING; GENETIC ASSOCIATION; GENETIC DATABASE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PREDICTION; REAL TIME POLYMERASE CHAIN REACTION; BIOLOGY; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; RECURRENT DISEASE;

BIOLOGICAL MARKERS; COLORECTAL NEOPLASMS; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECURRENCE; RNA, MESSENGER;

EID: 84863173885     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031587     Document Type: Article

References (46)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
2. Weitz J, Koch M, Debus J, Hohler T, Galle PR, et al. (2005) Colorectal cancer. Lancet 365: 153-165.
3. Yang L, Parkin DM, Li L, Chen Y, (2003) Time trends in cancer mortality in China: 1987-1999. Int J Cancer 106: 771-783.
4. Wolpin BM, Meyerhardt JA, Mamon HJ, Mayer RJ, (2007) Adjuvant treatment of colorectal cancer. CA Cancer J Clin 57: 168-185.
5. Longo WE, Johnson FE, (2002) The preoperative assessment and postoperative surveillance of patients with colon and rectal cancer. Surg Clin North Am 82: 1091-1108.
6. Schickel R, Boyerinas B, Park SM, Peter ME, (2008) MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 27: 5959-5974.
7. Hammond SM, (2007) MicroRNAs as tumor suppressors. Nat Genet 39: 582-583.
8. Liu W, Mao SY, Zhu WY, (2007) Impact of tiny miRNAs on cancers. World J Gastroenterol 13: 497-502.
9. Iorio MV, Croce CM, (2009) MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 27: 5848-5856.
10. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
11. Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM, (2003) bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113: 25-36.
12. Chen CZ, Li L, Lodish HF, Bartel DP, (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science 303: 83-86.
13. Lee YS, Dutta A, (2009) MicroRNAs in cancer. Annu Rev Pathol 4: 199-227.
14. Motoyama K, Inoue H, Takatsuno Y, Tanaka F, Mimori K, et al. (2009) Over- and under-expressed microRNAs in human colorectal cancer. Int J Oncol 34: 1069-1075.
15. Aslam MI, Taylor K, Pringle JH, Jameson JS, (2009) MicroRNAs are novel biomarkers of colorectal cancer. Br J Surg 96: 702-710.
16. Manne U, Shanmugam C, Bovell L, Katkoori VR, Bumpers HL, (2010) miRNAs as biomarkers for management of patients with colorectal cancer. Biomark Med 4: 761-770.
17. Xi Y, Edwards JR, Ju J, (2007) Investigation of miRNA biology by bioinformatic tools and impact of miRNAs in colorectal cancer-regulatory relationship of c-Myc and p53 with miRNAs. Cancer Inform 3: 245-253.
18. Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, et al. (2005) Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 37: 766-770.
19. Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk RH, et al. (2005) Phylogenetic shadowing and computational identification of human microRNA genes. Cell 120: 21-24.
20. Peng X, Li Y, Walters KA, Rosenzweig ER, Lederer SL, et al. (2009) Computational identification of hepatitis C virus associated microRNA-mRNA regulatory modules in human livers. BMC Genomics 10: 373.
21. Ruike Y, Ichimura A, Tsuchiya S, Shimizu K, Kunimoto R, et al. (2008) Global correlation analysis for micro-RNA and mRNA expression profiles in human cell lines. J Hum Genet 53: 515-523.
22. Lee Y, Yang X, Huang Y, Fan H, Zhang Q, et al. (2010) Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis. PLoS Comput Biol 6: e1000730.
23. Joshi A, De Smet R, Marchal K, Van de Peer Y, Michoel T, (2009) Module networks revisited: computational assessment and prioritization of model predictions. Bioinformatics 25: 490-496.
24. Tsai HL, Yeh YS, Yu FJ, Lu CY, Chen CF, et al. (2009) Predicting factors of postoperative relapse in T2-4N0M0 colorectal cancer patients via harvesting a minimum of 12 lymph nodes. Int J Colorectal Dis 24: 177-183.
25. Matsuyama T, Ishikawa T, Mogushi K, Yoshida T, Iida S, et al. (2010) MUC12 mRNA expression is an independent marker of prognosis in stage II and stage III colorectal cancer. Int J Cancer 127: 2292-2299.
26. Huang JC, Babak T, Corson TW, Chua G, Khan S, et al. (2007) Using expression profiling data to identify human microRNA targets. Nat Methods 4: 1045-1049.
27. Farh KK, Grimson A, Jan C, Lewis BP, Johnston WK, et al. (2005) The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science 310: 1817-1821.
28. Lottaz C, Yang X, Scheid S, Spang R, (2006) OrderedList-a bioconductor package for detecting similarity in ordered gene lists. Bioinformatics 22: 2315-2316.
29. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80.
30. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ, (2006) miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34: D140-144.
31. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ, (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res 36: D154-158.
32. John B, Enright AJ, Aravin A, Tuschl T, Sander C, et al. (2004) Human MicroRNA targets. PLoS Biol 2: e363.
33. Lewis BP, Burge CB, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
34. Scheid S, Spang R, (2004) A stochastic downhill search algorithm for estimating the local false discovery rate. IEEE/ACM Trans Comput Biol Bioinform 1: 98-108.
35. Scheid S, Spang R, (2005) twilight; a Bioconductor package for estimating the local false discovery rate. Bioinformatics 21: 2921-2922.
36. Fisher RA, (1932) Statistical Methods for Research Workers 4 London Oliver and Boyd.
37. Becker H, (1995) [Surgery of colorectal carcinoma]. Praxis (Bern 1994) 84: 1371-1372.
38. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, et al. (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198.
39. Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TL, et al. (2007) MicroRNA expression profiling in prostate cancer. Cancer Res 67: 6130-6135.
40. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070.
41. Park SY, Lee JH, Ha M, Nam JW, Kim VN, (2009) miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat Struct Mol Biol 16: 23-29.
42. Leslie A, Carey FA, Pratt NR, Steele RJ, (2002) The colorectal adenoma-carcinoma sequence. Br J Surg 89: 845-860.
43. Kobayashi H, Mochizuki H, Sugihara K, Morita T, Kotake K, et al. (2007) Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study. Surgery 141: 67-75.
44. Smith JJ, Deane NG, Wu F, Merchant NB, Zhang B, et al. (2010) Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology 138: 958-968.
45. Brosens RP, Belt EJ, Haan JC, Buffart TE, Carvalho B, et al. (2010) Deletion of chromosome 4q predicts outcome in stage II colon cancer patients. Cell Oncol.
46. Watanabe T, Kobunai T, Sakamoto E, Yamamoto Y, Konishi T, et al. (2009) Gene expression signature for recurrence in stage III colorectal cancers. Cancer 115: 283-292.